CXCL12 and breast cancer: The use of highly specific inhibitors of E-selectin inhibited entry of breast cancer cells into the vascular niche, whereas inhibition of the CXCR-4/CXCL-12 axis induced mobilisation of dormant breast cancer cells from the vascular niche into circulation [67].